ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Believers “Flout Fundamental Law Of Physics,” Park Says.

August 1, 2008

In Brief: Baker Leaves Wayne State To take Job as Deputy director, UM Cancer Center

March 23, 1994

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

Limb-Sparing Surgery May Not Offer Better Quality of Life

August 28, 2009

Funding opportunities listed.

November 12, 2004

Centers Got $35 Million In NIH Construction $$; Send In Applications, Branch Chief Says

July 24, 1992